Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Journal for Immunotherapy of Cancer|August 9, 2019
PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activityJianshu Wei, Can Luo, Yao Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 16, 2017
Phase I Study of Chimeric Antigen Receptor-Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract CancersYelei Guo, Kaichao Feng, Yang Liu, et al.
Protein & Cell|July 16, 2017
Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancersKaichao Feng, Yang Liu, Yelei Guo, et al.
Signal Transduction and Targeted Therapy|April 4, 2022
Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignanciesXin Yan, Deyun Chen, Yao Wang, et al.
Diabetes|May 24, 2012
Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: identification of a novel role in improving insulin sensitivityYiling Si, Yali Zhao, Haojie Hao, et al.
Signal Transduction and Targeted Therapy|October 24, 2023
Characteristics of premanufacture CD8<sup>+</sup>T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphomaYao Wang, Chuan Tong, Yuting Lu, et al.
Oncoimmunology|December 14, 2020
Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trialHanren Dai, Chuan Tong, Daiwei Shi, et al.
Cytotherapy|June 13, 2020
Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trialYang Liu, Yelei Guo, Zhiqiang Wu, et al.
Clinical Immunology (Orlando, Fla.)|September 3, 2013
Cytokine-induced killer (CIK) cells bound with anti-CD3/anti-CD133 bispecific antibodies target CD133(high) cancer stem cells in vitro and in vivoJianhua Huang, Chonghui Li, Yao Wang, et al.
European Journal of Immunology|July 29, 2021
Mutant B2M-HLA-E and B2M-HLA-G fusion proteins protects universal chimeric antigen receptor-modified T cells from allogeneic NK cell-mediated lysisYelei Guo, Beilei Xu, Zhiqiang Wu, et al.
Pageof 4